Latest Release of Symyx Notebook Strengthens Enterprise ELN

Latest Release of Symyx Notebook Strengthens Enterprise ELN

New Features Optimize Information-Driven R&D across Scientific Disciplines

SUNNYVALE, Calif., September 22, 2009 - Symyx Technologies, Inc. (Nasdaq: SMMX) today announced the release of Symyx Notebook 6.3, a major version upgrade that significantly enhances the Symyx vision of an enterprise electronic lab notebook (ELN) to support many scientific disciplines. Previous versions of Symyx Notebook had focused on biology, analytical and synthetic chemistry - version 6.3 rounds out the offering by adding parallel chemistry support for synthetic and medicinal chemistry.

 

"Responding to the needs of our large, diverse customer base, Symyx Notebook 6.3 enhances the general utility of Symyx Notebook and further improves scientists' ability to collaborate across the enterprise," said Dr. Trevor Heritage, president of Symyx's software business unit. "More and more, organizations in pharmaceuticals, biotechnology, chemicals and consumer products are demanding a single, enterprise ELN that provides improved productivity and operational agility and the ability to do more for less."

 

Symyx Notebook enables researchers to manage experimental workflows, capture intellectual property and share knowledge to gain scientific insight - all while optimizing time and resources in the laboratory. Symyx Notebook 6.3 improves support for synthetic chemists, analytical chemists and biologists in regulated and nonregulated environments by offering many new capabilities including support for parallel synthesis, library enumeration, searching of enumerated reactions and solid phase organic synthesis.

 

Key features of version 6.3 include:

  • Support for in-depth chemical representation combined with highly configurable library enumeration capabilities
  • Expansion of exact and substructure searching, which permits the retrieval of fractional salts and hydrates
  • Enablement of solid phase organic synthesis through the implementation of loading units and calculations
  • New "QuickData" capabilities that speed information capture with enhanced procedure editing and standard phrase lists for procedural text

For more information, visit www.symyx.com/elnsynthesis or contact [email protected]

 

About Symyx

Symyx Technologies, Inc. (Nasdaq: SMMX) enables companies in life sciences, chemicals and energy, and consumer and industrial products to transform scientific R&D and achieve extraordinary breakthroughs in productivity and return on investment. Symyx scientific information management enables scientists to design, execute, analyze, and report experimental results faster, more easily, and less expensively. Symyx microscale, parallel experimentation enables a single scientist to rapidly explore a broad experimental space and develop comprehensive data sets in days - not weeks or months. Symyx contract research delivers these advantages on a project basis and enables companies to increase R&D productivity, agility, and flexibility. Information about Symyx, including reports and other information filed by Symyx with the Securities and Exchange Commission, is available at www.symyx.com.

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.